Cited by 5Gestational Diabetes Research and ManagementMaternal and Neonatal HealthcareDiabetes Management and Research

Does Universal Screening for Gestational Diabetes Mellitus Improve Neonatal Outcomes in a Socially Vulnerable Population: A Prospective Study in French Guiana

Open access
Leonco, Loic, Kallel, Hatem, Nacher, Mathieu, Thelusme, Liliane, Dueymes, Maryvonne, Mhiri, Raoudha, Lalanne-Mistrih, Marie Laure, Sabbah, Nadia·2021·Frontiers in Endocrinology

Abstract

Aims/Introduction: French Guiana has a high prevalence of metabolic diseases, which are risk factors for gestational diabetes mellitus. Despite routine screening for gestational diabetes, treatment is still challenging because of health inequalities and different cultural representations of disease and pregnancy. This study was conducted to assess the role of early and universal GDM screening on obstetrical and neonatal complications in a socially deprived population. Materials and Methods: A prospective study was conducted, in the level III maternity in French Guiana. Of 2136 deliveries, 223 had gestational diabetes mellitus, 110 of whom were followed-up for 6 month to detail their social and laboratory parameters. Results: The prevalence of gestational diabetes in French Guiana (Cayenne Hospital) was estimated at 10.3%. The study population was very precarious with 70% of patients on welfare (universal health coverage or state medical assistance). The following obstetrical complications were observed: cesarean delivery (32%), history of miscarriage (26%) and preeclampsia (7.4%). Nevertheless, neonatal complications were rarely present and included hypoglycemia (2.8%) and macrosomia (2.8%). Conclusion: In French Guiana, gestational diabetes mellitus is very common. However, in a context of widespread poverty and diverse cultural representations, universal screening and monitoring limited the risk of macrosomia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2021.644770

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In French Guiana, the gestational diabetes mellitus prevalence was 10.3% in a prospective study.

    “Similar results for GDM prevalence at 10.3% were presented by Leonco et al. in their prospective study performed in French Guiana, an overseas department of France, in South America [79].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. [1]Article - Bulletin Épidémiologique Hebdomadaire. Available at: http://beh.santepubliquefrance.fr/beh/2020/2-3/2020_2-3_3.html (Accessed April 8, 2020).
  2. [2]Leneuve-Dorilas M Favre A Carles G Louis A Nacher M. Risk Factors for Premature Birth in French Guiana: The Importance of Reducing Health Inequalities. J Matern-Fetal Neonatal Med (2019) 32(8): 1388–96. 10.1080/14767058.2017.1403578 29130760 · DOI
  3. [3]Mhiri R Mvogo A Kamga A Yassinguezo S Fagla H Dotou D. Epidemiology and Maternal Prognosis of Hypertension Disorders of Pregnancy in French Guiana. Pregnancy Hypertens (2020) 20: 96– 101. 10.1016/j.preghy.2020.03.010 32224440 · DOI
  4. [4]Daigre J-L Atallah A Boissin J-L Jean-Baptiste G Kangambega P Chevalier H. The Prevalence of Overweight and Obesity, and Distribution of Waist Circumference, in Adults and Children in the French Overseas Territories: The PODIUM Survey. Diabetes Metab (2012) 38(5): 404–11. 10.1016/j.diabet.2012.03.008 22626474 · DOI
  5. [5]Sabbah N Massicard M Mathieu N. Specificities of the Diabetic Population in French Guiana: The Health Barometer Survey. Curr Diabetes Rev (2021) 1: 1 10.2174/1573399817666210129103506 33511949 · DOI
  6. [6]Van Melle A Cropet C Parriault M-C Adriouch L Lamaison H Sasson F. Renouncing Care in French Guiana: The National Health Barometer Survey. BMC Health Serv Res (2019) 19(1): 99. 10.1186/s12913-019-3895-6 30728033 PMC6366016 · DOI
  7. [7]Cruz-Hernández J Hernández-García P Lang-Prieto J Yanes-Quesada M Iglesias-Marichal I Márquez-Guillén A. Controversies in Screening and Diagnosis of Gestational Diabetes: Cuba’s Position. MEDICC Rev (2016) 18(3): 35–9. 10.37757/MR2016.V18.N3.9 27510937 · DOI
  8. [8]McIntyre HD Catalano P Zhang C Desoye G Mathiesen ER Damm P. Gestational Diabetes Mellitus. Nat Rev Dis Primer (2019) 5(1): 47. 10.1038/s41572-019-0098-8 31296866 · DOI · Paper page
  9. [9]Vignoles P Gire C Mancini J Bretelle F Boubli L Janky E. Gestational Diabetes: A Strong Independent Risk Factor for Severe Neonatal Respiratory Failure After 34 Weeks. Arch Gynecol Obstet (2011) 284(5): 1099–104. 10.1007/s00404-010-1810-9 21170541 · DOI
  10. [10]Senat M-V Deruelle P. Gestational Diabetes Mellitus. Gynecol Obstet Fertil (2016) 44(4): 244–7. 10.1016/j.gyobfe.2016.01.009 26948827 · DOI
  11. [11]Kim SY Sappenfield W Sharma AJ Wilson HG Bish CL Salihu HM. Racial/Ethnic Differences in the Prevalence of Gestational Diabetes Mellitus and Maternal Overweight and Obesity, by Nativity, Florida, 2004-2007. Obes Silver Spring Md (2013) 21(1): E33–40. 10.1002/oby.20025 PMC4392762 23404915 · DOI
  12. [12]Cosson E Cussac-Pillegand C Benbara A Pharisien I Jaber Y Banu I. The Diagnostic and Prognostic Performance of a Selective Screening Strategy for Gestational Diabetes Mellitus According to Ethnicity in Europe. J Clin Endocrinol Metab (2014) 99(3): 996– 1005. 10.1210/jc.2013-3383 24423342 · DOI
  13. [13]International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy. Diabetes Care (2010) 33(3): 676–82. 10.2337/dc09-1848 PMC2827530 20190296 · DOI · Paper page
  14. [14]Billionnet C Mitanchez D Weill A Nizard J Alla F Hartemann A. Gestational Diabetes and Adverse Perinatal Outcomes From 716,152 Births in France in 2012. Diabetologia (2017) 60(4): 636–44. 10.1007/s00125-017-4206-6 PMC6518373 28197657 · DOI
  15. [15]Ducarme G Desroys Du Roure F Le Thuaut A Grange J Dimet J Crepin-Delcourt I. Efficacy of Maternal and Biological Parameters At the Time of Diagnosis of Gestational Diabetes Mellitus in Predicting Neonatal Morbidity. Eur J Obstet Gynecol Reprod Biol (2018) 221: 113–8. 10.1016/j.ejogrb.2017.12.036 29278829 · DOI
  16. [17]Mendes N Alves M Andrade R Ribeiro RT Papoila AL Serrano F. Association Between Glycated Albumin, Fructosamine, and HbA1c With Neonatal Outcomes in a Prospective Cohort of Women With Gestational Diabetes Mellitus. Int J Gynaecol Obstet (2019) 146(3): 326–32. 10.1002/ijgo.12897 31242319 · DOI
  17. [18]Huet J Beucher G Rod A Morello R Dreyfus M. Joint Impact of Gestational Diabetes and Obesity on Perinatal Outcomes. J Gynecol Obstet Hum Reprod (2018) 47(9): 469–76. 10.1016/j.jogoh.2018.08.003 30153508 · DOI
  18. [19]Rouget F Lebreton J Kadhel P Monfort C Bodeau-Livinec F Janky E. Medical and Sociodemographic Risk Factors for Preterm Birth in a French Caribbean Population of African Descent. Matern Child Health J (2013) 17(6): 1103–11. 10.1007/s10995-012-1112-x 22923284 · DOI
  19. [20]Dooley SL Metzger BE Cho N Liu K. The Influence of Demographic and Phenotypic Heterogeneity on the Prevalence of Gestational Diabetes Mellitus. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet (1991) 35(1): 13–8. 10.1016/0020-7292(91)90057-c 1680070 · DOI
  20. [21]Kuo C-H Chen S-C Fang C-T Nien F-J Wu E-T Lin S-Y. Screening Gestational Diabetes Mellitus: The Role of Maternal Age. PLoS One (2017) 12(3): e0173049. 10.1371/journal.pone.0173049 28296923 PMC5351872 · DOI
  21. [22]Legardeur H Girard G Mandelbrot L. [Screening of Gestational Diabetes Mellitus: A New Consensus]? Gynecol Obstet Fertil (2011) 39(3): 174–9. 10.1016/j.gyobfe.2010.12.009 21388854 · DOI
  22. [25]Gomes DJ Kaufman B Aluisio AR Kendall S Thomas V Bloem C. Assessment of Acute Obstetrical Needs and the Potential Utility of Point-Of-Care Ultrasound in the North East Region of Haiti: A Cross-Sectional Study. Ann Glob Health (2020) 86(1): 72. 10.5334/aogh.2597 32676301 PMC7333557 · DOI
  23. [26]Valcin J Jean-Charles S Malfa A Tucker R Dorcélus L Gautier J. Mortality, Morbidity and Clinical Care in a Referral Neonatal Intensive Care Unit in Haiti. PLoS One (2020) 15(10): e0240465. 10.1371/journal.pone.0240465 33052937 PMC7556516 · DOI
  24. [27]Poolsup N Suksomboon N Amin M. Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. PLoS One (2014) 9(3): e92485. 10.1371/journal.pone.0092485 24658089 PMC3962411 · DOI
  25. [28]Wang Z Kanguru L Hussein J Fitzmaurice A Ritchie K. Incidence of Adverse Outcomes Associated With Gestational Diabetes Mellitus in Low- and Middle-Income Countries. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet (2013) 121(1): 14–9. 10.1016/j.ijgo.2012.10.032 23321368 · DOI
  26. [29]Basri NI Mahdy ZA Ahmad S Karim AKA Shan LP Manaf MRA. The World Health Organization (WHO) Versus The International Association of Diabetes and Pregnancy Study Group (IADPSG) Diagnostic Criteria of Gestational Diabetes Mellitus (GDM) and Their Associated Maternal and Neonatal Outcomes. Horm Mol Biol Clin Investig (2018) 34: 1– 9. 10.1515/hmbci-2017-0077 29453924 · DOI
  27. [30]Buchanan TA Xiang AH Page KA. Gestational Diabetes Mellitus: Risks and Management During and After Pregnancy. Nat Rev Endocrinol (2012) 8(11): 639–49. 10.1038/nrendo.2012.96 PMC4404707 22751341 · DOI · Paper page
  28. [31]Crowther CA Hiller JE Moss JR McPhee AJ Jeffries WS Robinson JS. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. N Engl J Med (2005) 352(24): 2477–86. 10.1056/NEJMoa042973 15951574 · DOI · Paper page
  29. [32]Siricharoenthai P Phupong V. Diagnostic Accuracy of HbA1c in Detecting Gestational Diabetes Mellitus. J Matern Fetal Neonatal Med (2020) 33(20): 3497–500. 10.1080/14767058.2019.1576169 30691324 · DOI
  30. [33]Mendes N Tavares Ribeiro R Serrano F. Beyond Self-Monitored Plasma Glucose and HbA1c: The Role of Non-Traditional Glycaemic Markers in Gestational Diabetes Mellitus. J Obstet Gynaecol J Inst Obstet Gynaecol (2018) 38(6): 762–9. 10.1080/01443615.2017.1412409 29620435 · DOI
  31. [34]Kwon SS Kwon J-Y Park Y-W Kim Y-H Lim J-B. HbA1c for Diagnosis and Prognosis of Gestational Diabetes Mellitus. Diabetes Res Clin Pract (2015) 110(1): 38– 43. 10.1016/j.diabres.2015.07.014 26344325 · DOI
  32. [36]Agarwal MM Dhatt GS Othman Y Ljubisavljevic MR. Gestational Diabetes: An Evaluation of Serum Fructosamine as a Screening Test in a High-Risk Population. Gynecol Obstet Invest (2011) 71(3): 207–12. 10.1159/000318705 21160150 · DOI
  33. [37]Nasrat HA Ajabnoor MA Ardawi MS. Fructosamine as a Screening-Test for Gestational Diabetes Mellitus: A Reappraisal. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet (1991) 34(1): 27– 33. 10.1016/0020-7292(91)90534-c 1671017 · DOI
  34. [38]Gingras V Rifas-Shiman SL Switkowski KM Oken E Hivert M-F. Mid-Pregnancy Fructosamine Measurement-Predictive Value for Gestational Diabetes and Association With Postpartum Glycemic Indices. Nutrients (2018) 10: 1– 11. 10.3390/nu10122003 PMC6315870 30567328 · DOI
  35. [39]Bomback AS Rekhtman Y Whaley-Connell AT Kshirsagar AV Sowers JR Chen S-C. Gestational Diabetes Mellitus Alone in the Absence of Subsequent Diabetes Is Associated With Microalbuminuria: Results From the Kidney Early Evaluation Program (Keep). Diabetes Care (2010) 33(12): 2586–91. 10.2337/dc10-1095 PMC2992195 20807871 · DOI
  36. [40]Zen M Padmanabhan S Cheung NW Kirby A Jesudason S Alahakoon TI. Microalbuminuria as an Early Predictor of Preeclampsia in the Pre-Gestational Diabetic Population: A Prospective Cohort Study. Pregnancy Hypertens (2019) 15: 182–8. 10.1016/j.preghy.2019.01.010 30825920 · DOI
  37. [41]Bahasadri S Kashanian M Khosravi Z. Comparison of Pregnancy Outcome Among Nulliparas With and Without Microalbuminuria At the End of the Second Trimester. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet (2011) 115(1): 34–6. 10.1016/j.ijgo.2011.04.012 21794863 · DOI
  38. [42]Kramer MS Demissie K Yang H Platt RW Sauvé R Liston R. The Contribution of Mild and Moderate Preterm Birth to Infant Mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA (2000) 284(7): 843–9. 10.1001/jama.284.7.843 10938173 · DOI
  39. [43]Zar HJ Pellowski JA Cohen S Barnett W Vanker A Koen N. Maternal Health and Birth Outcomes in a South African Birth Cohort Study. PLoS One (2019) 14(11): e0222399. 10.1371/journal.pone.0222399 31751344 PMC6874071 · DOI
  40. [44]Cosson E Bihan H Reach G Vittaz L Carbillon L Valensi P. Psychosocial Deprivation in Women With Gestational Diabetes Mellitus is Associated With Poor Fetomaternal Prognoses: An Observational Study. BMJ Open (2015) 5(3): e007120. 10.1136/bmjopen-2014-007120 PMC4360844 25748416 · DOI

Cited by

Sorted by citations

Authors
Leonco, L., Kallel, H., Nacher, M., Thelusme, L., Dueymes, M., Mhiri, R., Lalanne-Mistrih, M. L., & Sabbah, N.
Affiliations
  • Centre Hospitalier Andrée Rosemon (GF)
  • Inserm (FR)
Corresponding author
Sabbah, Nadia
Venue
Frontiers in Endocrinology
Published
2021-05-21
Volume
12
Pages
644770-644770
ISSN
1664-2392 (ISSN-L)
OpenAlex
W3164386935
Cited by
5
References
1
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 2
FWCI
0.68
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Health Professions › General Health Professions › Maternal and Neonatal Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, universal screening, neonatal outcomes, socially vulnerable populations, health disparities, French Guiana, macrosomia, neonatal hypoglycemia, preeclampsia, cesarean section, miscarriage, poverty
MeSH terms
Abortion, Spontaneous, Adolescent, Adult, Cesarean Section, Cultural Characteristics, Female, Fetal Macrosomia, French Guiana, Humans, Hypoglycemia, Infant, Newborn, Mass Screening, Middle Aged, Obstetrics, Pre-Eclampsia, Pregnancy, Prospective Studies, Risk Factors, Social Class, Diabetes, Gestational, Treatment Outcome, Vulnerable Populations, Health Status Disparities, Healthcare Disparities, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review